Venrock Healthcare Capital Partners EG, L.P. sold $3.6M of KalVista Pharmaceuticals (KALV)

Executed Mar 25, disclosed Mar 27, 2 days later.

Value, as filed

$3.6M

211,288 sh across 3 lots

Executed

Mar 25

the trade date, as filed

Disclosed

Mar 27

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VP Venrock Healthcare Capital Partners EG, L.P. 10% owner profile →

Venrock Healthcare Capital Partners EG, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in KALV. The largest single filing was $3.6M of KALV (211,288 sh across 3 lots, as filed), executed Mar 25.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Venrock Healthcare Capital Partners EG, L.P. in KALV

KALVPURCHASE KalVista Pharmaceuticals, Inc. $236K
25,000 sh × $9.42
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET